Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Celldex Therapeutics, Inc. (CLDX)

Add CLDX Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/4/2017 4:30:18 PM - Followers: 98 - Board type: Free - Posts Today: 0



 Celldex Therapeutics, Inc. (CLDX)





Company Information:
Celldex Therapeutics, Inc.
222 Cameron Drive
Suite 400
Phillipsburg, NJ. 08865
Phone: 908-454-7120
Fax:  908-454-1911
Celldex Therapeutics (NASDAQ: CLDX) was founded based on a fundamental scientific belief that harnessing the power of the immune system would break significant barriers in drug development for a host of devastating diseases. The Company’s pipeline is comprised of therapeutic antibodies, antibody drug conjugates, immune system modulators and vaccines that we believe have a higher probability of success because they are targeted to specific patient populations with high unmet medical need whose diseases express specific markers—including many underserved or completely un-served orphan indications. This has created a leading pipeline in immunotherapy comprised of two candidates in pivotal trials, one in brain cancer and one in triple negative breast cancer, four additional clinical candidates in a range of difficult-to-treat indications and a robust preclinical engine.
Many of our clinical programs seek to leverage the power of the immune system’s response by combining therapeutic approaches to maximize their potential. Key to this strategy is our ability to understand our own asset base while also identifying promising external technologies that will complement it. In 2005, Celldex was spun out of the New Jersey based biopharmaceutical company Medarex (now a subsidiary of the Bristol-Myers Squibb Company) and, in connection with this transaction, Celldex retains the rights to obtain exclusive commercial licenses to proprietary monoclonal antibodies raised against certain antigens utilizing the Medarex UltiMAb technology platform. Since its inception, Celldex has also acquired four companies, folding in three assets, and in-licensed/purchased an additional two assets. With the potential for positive results in ongoing late stage programs, the next stage in Celldex’s development is to become a fully-integrated commercial entity.
Product Pipeline:
News and Press Releases:


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes
Events and Presentations:
SEC Filings:
Transfer Agent:
Computershare, Inc.
250 Royall Street
Canton, MA 02021
Phone: (US) 800-736-3001 / (Int’l) 781-575-2000
Share Structure:
See SEC filings
Investor Relations:
Sarah Cavanaugh
Vice President
Investor Relations & Corporate Communications


November 1, 2016

yes Celldex Expands Antibody and Immuno-Oncology Portfolio with the Acquisition of Kolltan Pharmaceuticals yes

yes November 8, 2016  yes

From a financial standpoint, the biggest update from Celldex related to its cash position. The biotech reported cash, cash equivalents, and marketable securities totaling $203.2 million at the end of the third quarter. Celldex used $24 million in cash during the quarter. 







All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.


Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.


Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:



Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CLDX News: Statement of Changes in Beneficial Ownership (4) 10/03/2017 05:29:05 PM
CLDX News: Initial Statement of Beneficial Ownership (3) 10/03/2017 05:16:05 PM
CLDX News: Current Report Filing (8-k) 10/03/2017 08:10:13 AM
CLDX News: Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs 10/03/2017 08:00:00 AM
CLDX News: Statement of Changes in Beneficial Ownership (4) 10/02/2017 04:10:55 PM
#1464   I bought back in early this week for noretreat 10/04/17 04:30:18 PM
#1463   And? Is CLDX gonna come out with some 2014shelby 10/04/17 10:22:24 AM
#1462   Agree. In addition on the biggest up days trebeg 10/04/17 10:21:54 AM
#1461   insiders! harry crumb 10/04/17 09:15:04 AM
#1460   well yeah its better than 3! harry crumb 10/02/17 02:23:20 PM
#1459   Harry...I'd take that and be very happy. CLDX$$$$ trebeg 09/26/17 11:27:03 PM
#1458   A lot of buying leading up to the trebeg 09/26/17 11:24:03 PM
#1457   100% agree! i do believe this crawls to harry crumb 09/26/17 07:55:08 PM
#1456   What happen last week was Insurance Buying. Today fwb 09/26/17 03:03:03 PM
#1455   Relax Shelby. Won't happen until FDA approval which trebeg 09/26/17 12:33:24 PM
#1454   patience my friend, institutional ownership is nearing 60%, harry crumb 09/26/17 06:50:22 AM
#1453   PPS still $3. PPS been down for a 2014shelby 09/25/17 08:45:59 PM
#1452   interest is coming back for a reason, approval!! $$$ harry crumb 09/25/17 03:48:57 PM
#1451   where were you? taylorfleming 09/25/17 02:53:01 PM
#1450   That was a nice little ride. Hopefully we erehdogmai 09/25/17 12:08:37 PM
#1449   Have plenty Harry but will add more if trebeg 09/25/17 11:46:43 AM
#1448   agree, but adding shares now will make u harry crumb 09/25/17 08:16:41 AM
#1447   This stock is event driven and it will trebeg 09/25/17 12:04:37 AM
#1446   You are correct, I just think one day redskins020 09/24/17 12:13:51 AM
#1445   CLDX PPS still below $3. Just seems to 2014shelby 09/23/17 01:16:20 PM
#1444   wow a huge buy held back! institutional purchase, harry crumb 09/13/17 07:52:49 PM
#1443   How about now? 2014shelby 09/12/17 05:46:21 PM
#1442   huge upside may happen on positive catalysts, more harry crumb 09/12/17 10:10:21 AM
#1441   Good. $5+ coming? 2014shelby 09/11/17 09:52:05 PM
#1440   cldx needs to be outgoing with some news harry crumb 09/09/17 03:27:57 PM
#1439   all the gains gone, pump an dump by harry crumb 09/08/17 11:50:04 AM
#1438   Thanks. You seem to be on top of 2014shelby 09/07/17 12:45:59 PM
#1437   im thinking mutual fund purchases, before news hits. harry crumb 09/07/17 12:36:57 PM
#1436   Yes. Any thoughts on why? 2014shelby 09/07/17 12:30:30 PM
#1435   spike! !!! harry crumb 09/07/17 11:55:37 AM
#1434   gotcha harry crumb 08/31/17 07:57:37 PM
#1433   I agree maybe higher, but That will be fwb 08/31/17 05:57:42 PM
#1432   straight to 15 on supported news of a harry crumb 08/31/17 05:17:52 PM
#1431   Slow walk up to $3.00 fwb 08/31/17 11:54:07 AM
#1430   look for cldx to add market value over harry crumb 08/30/17 08:56:04 AM
#1429   That's a major drop given that CLDX is 2014shelby 08/19/17 05:31:31 PM
#1428   agree, the pipeline is robust at that, theres harry crumb 08/18/17 10:45:53 PM
#1427   Yeah, I wouldn't expect much movement until we trebeg 08/08/17 03:25:12 PM
#1426   Simply a pre earnings bump...likely move in one ConstitutionNow 08/08/17 11:52:25 AM
#1425   Why's CLDX moving up or is this a 2014shelby 08/08/17 10:22:38 AM
#1423   take a hike traderclay! harry crumb 08/04/17 09:40:35 PM
#1422   * * $CLDX Video Chart 08-01-17 * * ClayTrader 08/01/17 05:19:38 PM
#1421   30 minute Technicals looking very good for a ConstitutionNow 07/25/17 05:54:17 PM
#1419   I think I may be flipping some and 2014shelby 06/25/17 12:14:10 PM
#1418   Yeah, $4 would be good at this point trebeg 06/25/17 12:10:25 PM
#1417   Good point. How about just $4 first? CLDX 2014shelby 06/23/17 09:35:41 PM
#1416   Harry...I would love to see your scenario play trebeg 06/23/17 06:49:52 PM
#1415   all the insiders are buying up shares as harry crumb 06/22/17 11:54:46 PM
#1414   Will CLDX ever hit $4 again? 2014shelby 06/22/17 06:46:16 PM
#1413   there will be massive covering coming if their harry crumb 06/21/17 10:24:55 AM